Soluble mic neutralizing monoclonal antibody for treating cancer

作者: Jennifer Wu

DOI:

关键词: AntibodyVirologyBiologyMonoclonal antibodyMajor histocompatibility complexCancer

摘要: Disclosed are compositions and methods relating to antibodies that bind soluble Major Histocompatibility Complex class I chain-related (sMIC). Specifically, disclosed designed or selected inhibit sMIC (e.g. neutralize sMIC) shed from MIC+ tumors. Further of using the for treatment MlC-positive cancers.

参考文章(225)
Ikuo Fujii, Antibody affinity maturation by random mutagenesis. Methods of Molecular Biology. ,vol. 248, pp. 345- 359 ,(2004) , 10.1385/1-59259-666-5:345
Kalavathy Sitaraman, Deb K. Chatterjee, High-throughput protein expression using cell-free system. Methods of Molecular Biology. ,vol. 498, pp. 229- 244 ,(2009) , 10.1007/978-1-59745-196-3_15
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
Marine Champsaur, Lewis L. Lanier, Effect of NKG2D ligand expression on host immune responses Immunological Reviews. ,vol. 235, pp. 267- 285 ,(2010) , 10.1111/J.0105-2896.2010.00893.X
F. Stephen Hodi, Catica Fonesca, Masahisa Jinushi, Glenn Dranoff, Methods for treating mica-related disorders ,(2007)
Jacobus Johannes Maria van Dongen, Frank Jakob Theodor Staal, Fret probes and methods for detecting interacting molecules ,(2003)